The Supreme Court today (May 13) dismissed the plea filed by the Competition Commission of India (CCI) challenging a glass ...

The latest portfolio update by Kotak Institutional Equities enhances allocations for InterGlobe Aviation and Pidilite, ...

There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of ...

Managing Director & Global CEO Umang Vohra expressed confidence in the company's ability to expand, driven by a multi-pronged ...

The Indian stock markets ended lower on Tuesday as investors booked profits following Monday’s sharp rally. The sell-off was ...

For the year so far, FIIs have been net sellers of shares worth Rs 1.25 lakh crore, while DIIs have net bought Rs 2.27 lakh ...

Donald Trump’s new drug pricing order has the Indian pharmaceutical industry on edge. While CDMOs may benefit, generics and ...

While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account ...

The Indian Pharmaceutical Alliance (IPA) emphasizes the need to balance innovation with affordability in response to ...

The key equity indices traded with major losses in early afternoon trade, weighed down by profit booking and weakness in ...

The BSE Sensex witnessed sharp profit-booking in Tuesday’s session, dragged down by heavyweight IT stocks. The index declined ...

The BSE Sensex tumbled 1,281.68 points, or 1.5%, to close at 81,148.22 levels, and the NSE Nifty50 settled at 24,578.35, down ...